Alane P Barnes sold $1.2M of BioCryst Pharmaceuticals (BCRX)

Executed Dec 1 2025, disclosed Dec 3 2025, 2 days later.

Value, as filed

$1.2M

161,680 sh across 3 lots

Executed

Dec 1 2025

the trade date, as filed

Disclosed

Dec 3 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AB Alane P Barnes Chief Legal Officer profile →

Alane P Barnes (Chief Legal Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in BioCryst Pharmaceuticals, Inc. (BCRX). The largest single filing was $1.4M of BCRX (150,000 sh × $9.15, as filed), executed Mar 16.

The name

BCRX BioCryst Pharmaceuticals, Inc. BCRX · Healthcare · 10 filings in 24 months ticker →

Healthcare · BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Alane P Barnes in BCRX

BCRXSALE BioCryst Pharmaceuticals, Inc. $596K
62,500 sh × $9.54
Exec May 13
Filed May 15 · 5:30 PM ET BCRXSALE BioCryst Pharmaceuticals, Inc. $1.4M
150,000 sh × $9.15
Exec Mar 16
Filed Mar 18 · 5:30 PM ET BCRXSALE BioCryst Pharmaceuticals, Inc. $167K
21,773 sh × $7.65
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET BCRXSALE BioCryst Pharmaceuticals, Inc. $162K
21,210 sh × $7.65
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET